Abstract
Atherosclerosis leads to narrowing of vessels and acute coronary syndrome resulting in ischemic events due to either vasospasm or decreased blood flow. Atherosclerosis and acute coronary syndrome are more common in diabetes mellitus. Hyperglycemia and hypercholesterolemia in diabetes predispose the arteries to plaque development. Smoking, hypertension, male sex, and family history or genetic susceptibility are other predisposing factors for plaque development. Depending on the size, morphology, and symptoms of the patients, plaques can be classified as stable and unstable plaques. Unstable plaques are characterized by the presence of thin fibrous cap, necrotic core, and proliferation of vascular smooth muscle cells, angiogenesis and calcification. Plaque formation initiates with fatty streak and progresses through atheroma, atheromatous plaque to fibroatheromatous plaque. Fibroatheromatous plaques with thick fibrous cap are stable plaques. Thinning of the fibrous cap makes a plaque unstable, prone to rupture and thrombus formation. Mechanisms such as increased inflammation, foam cell deposition, impaired repair mechanism, endothelial cell dysfunction, vascular smooth muscle cell proliferation, angiogenesis, intra-plaque hemorrhage, and calcification which facilitate the plaque rupture are increased in diabetes mellitus. Thus, diabetes mellitus increases the prevalence of plaque formation and rupture. Diabetes mellitus affects various cellular and molecular effectors involved in plaque development and rupture. Understanding these cellular and molecular effectors and involved mechanisms in association with diabetes mellitus is essential for the development of potential therapeutic strategies. This review is a critical overview on the effect of hyperglycemia in diabetes mellitus on the pathogenesis of plaque formation and rupture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bentzon JF, Otsuka F, Virmani R, Falk E (2014) Mechanisms of plaque formation and rupture. Circ Res 114:1852–1866
Wentzel JJ, Chatzizisis YS et al (2012) Endothelial shear stress in the evolution of coronary atherosclerotic plaque and vascular remodelling: current understanding and remaining questions. Cardiovasc Res 96:234–243
Rao VH, Rai V, Stoupa S, Agrawal DK (2015) Blockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells. Am J Physiol Heart Circ Physiol 309:H1075–H1086
Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222
Cahill LE, Jensen MK, Chiuve SE et al (2015) The risk of coronary heart disease associated with glycosylated hemoglobin of 6.5% or greater is pronounced in the haptoglobin 2-2 genotype. J Am Coll Cardiol 66:1791–1799
Merino J, Leong A, Dupuis J, et al. (2016) OR27-5: genetically driven hyperglycemia increases risk of coronary artery disease distinctly from type 2 diabetes. Diabetes Care 40(5):687–693
Paneni F, Beckman JA, Creager MA, Cosentino F (2013) Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 34:2436–2443
Gleissner CA, Galkina E, Nadler JL, Ley K (2007) Mechanisms by which diabetes increases cardiovascular disease. Drug Discov Today Dis Mech 4:131–140
Kubo T, Imanishi T, Takarada S et al (2007) Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 50:933–939
Edsfeldt A, Goncalves I, Grufman H et al (2014) Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes. Arterioscler Thromb Vasc Biol 34:2143–2150
Skalen K, Gustafsson M, Rydberg EK et al (2002) Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 417:750–754
Libby P, Ridker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature 473:317–325
Subramanian M, Tabas I (2014) Dendritic cells in atherosclerosis. Semin Immunopathol 36:93–102
Leitinger N, Schulman IG (2013) Phenotypic polarization of macrophages in atherosclerosis. Arterioscler Thromb Vasc Biol 33:1120–1126
Kolodgie FD, Burke AP, Nakazawa G, Virmani R (2007) Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease? Arterioscler Thromb Vasc Biol 27:986–989
Stary HC (2001) The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol 88:16E–19E
Otsuka F, Sakakura K, Yahagi K, Joner M, Virmani R (2014) Has our understanding of calcification in human coronary atherosclerosis progressed? Arterioscler Thromb Vasc Biol 34:724–736
Davies MJ (2000) The pathophysiology of acute coronary syndromes. Heart 83:361–366
Niccoli G, Fracassi F, Crea F (2014) Pathophysiology and clinical significance of plaque rupture. Medicographia 36:37–44
Rao VH, Rai V, Stoupa S, Subramanian S, Agrawal DK (2016) Data on TREM-1 activation destabilizing carotid plaques. Data Brief 8:230–234
Rai V, Rao VH, Shao Z, Agrawal DK (2016) Dendritic cells expressing triggering receptor expressed on myeloid cells-1 correlate with plaque stability in symptomatic and asymptomatic patients with carotid stenosis. PLoS One 11:e0154802
Rao VH, Rai V, Stoupa S, Subramanian S, Agrawal DK (2016) Tumor necrosis factor-alpha regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosis. Atherosclerosis 248:160–169
Jagannathan-Bogdan M, McDonnell ME, Shin H et al (2011) Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 186:1162–1172
Dasu MR, Devaraj S, Park S, Jialal I (2010) Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 33:861–868
van Beijnum JR, Buurman WA, Griffioen AW (2008) Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). Angiogenesis 11:91–99
Mughal MM, Khan MK, DeMarco JK et al (2011) Symptomatic and asymptomatic carotid artery plaque. Expert Rev Cardiovasc Ther 9:1315–1330
Kato K, Yonetsu T, Kim SJ et al (2012) Comparison of nonculprit coronary plaque characteristics between patients with and without diabetes: a 3-vessel optical coherence tomography study. JACC Cardiovasc Interv 5:1150–1158
Koskinas KC, Sukhova GK, Baker AB et al (2013) Thin-capped atheromata with reduced collagen content in pigs develop in coronary arterial regions exposed to persistently low endothelial shear stress. Arterioscler Thromb Vasc Biol 33:1494–1504
Chang SC, Vivian Yang WC (2013) Hyperglycemia induces altered expressions of angiogenesis associated molecules in the trophoblast. Evid Based Complement Alternat Med 2013:457971
Lewandowski KC, Banach E, Bienkiewicz M, Lewinski A (2011) Matrix metalloproteinases in type 2 diabetes and non-diabetic controls: effects of short-term and chronic hyperglycaemia. Arch Med Sci 7:294–303
Shamhart PE, Luther DJ, Adapala RK et al (2014) Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts. Can J Physiol Pharmacol 92:598–604
Chait A, Bornfeldt KE (2009) Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res 50(Suppl):S335–S339
Rajmohan L, Deepa R, Mohan A, Mohan V (2000) Association between isolated hypercholesterolemia, isolated hypertriglyceridemia and coronary artery disease in south Indian type 2 diabetic patients. Indian Heart J 52:400–406
Hess K, Grant PJ (2011) Inflammation and thrombosis in diabetes. Thromb Haemost 105(Suppl 1):S43–S54
Chen NX, Duan D, O’Neill KD, Moe SM (2006) High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells. Nephrol Dial Transplant 21:3435–3442
Li X, Yang HY, Giachelli CM (2008) BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 199:271–277
Avogaro A, Fadini GP (2015) Mechanisms of ectopic calcification: implications for diabetic vasculopathy. Cardiovasc Diagn Ther 5:343–352
Tripodi A, Branchi A, Chantarangkul V et al (2011) Hypercoagulability in patients with type 2 diabetes mellitus detected by a thrombin generation assay. J Thromb Thrombolysis 31:165–172
Domingueti CP, Dusse LM, Carvalho M et al (2016) Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complicat 30:738–745
Purushothaman KR, Purushothaman M, Muntner P et al (2011) Inflammation, neovascularization and intra-plaque hemorrhage are associated with increased reparative collagen content: implication for plaque progression in diabetic atherosclerosis. Vasc Med 16:103–108
Vranes D, Cooper ME, Dilley RJ (1999) Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res 57:8–18
Tang M, Zhong M, Shang Y et al (2008) Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway. Cell Mol Life Sci 65:2924–2932
Brings S, Zhang S, Choong YS et al (2015) Diabetes-induced alterations in tissue collagen and carboxymethyllysine in rat kidneys: association with increased collagen-degrading proteinases and amelioration by Cu(II)-selective chelation. Biochim Biophys Acta 1852:1610–1618
Carr S, Farb A, Pearce WH, Virmani R, Yao JS (1996) Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg 23:755–766
Michel JB, Virmani R, Arbustini E, Pasterkamp G (2011) Intraplaque haemorrhages as the trigger of plaque vulnerability. Eur Heart J 32:1977–1985. 1985a, 1985b, 1985c
Hayden MR, Tyagi SC (2004) Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc Diabetol 3:1
Virmani R, Kolodgie FD, Burke AP et al (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 25:2054–2061
Carter A, Murphy MO, Turner NJ et al (2007) Intimal neovascularisation is a prominent feature of atherosclerotic plaques in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg 33:319–324
Ruiz E, Gordillo-Moscoso A, Padilla E et al (2006) Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high Bcl-2 expression. Diabetes 55:1243–1251
Acknowledgement
This work was supported by research grants R01 HL112597, R01 HL116042, and R01 HL120659 to DK Agrawal from the National Heart, Lung and Blood Institute, National Institutes of Health, USA. The content of this review article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Crown Copyright
About this chapter
Cite this chapter
Rai, V., Agrawal, D.K. (2017). Pathogenesis of the Plaque Vulnerability in Diabetes Mellitus. In: Kartha, C., Ramachandran, S., Pillai, R. (eds) Mechanisms of Vascular Defects in Diabetes Mellitus. Advances in Biochemistry in Health and Disease, vol 17. Springer, Cham. https://doi.org/10.1007/978-3-319-60324-7_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-60324-7_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-60323-0
Online ISBN: 978-3-319-60324-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)